Veracyte announces publication of clinical validation data for Afirma Xpression Atlas
Veracyte announced publication of new data demonstrating the clinical and analytical validity of its Afirmaź Xpression Atlas genomic test used to help guide surgery and treatment decisions for patients with thyroid cancer. The findings appear in the journal Frontiers in Endocrinology. September 11, 2019